Your browser doesn't support javascript.
loading
Treatment of malignant melanoma with nivolumab and vemurafenib combined with hypofractionated radiation therapy.
Ueki, Kazuhito; Kosaka, Yasuhiro; Kimino, Genki; Imagumbai, Toshiyuki; Takayama, Kenji; Kokubo, Masaki.
Affiliation
  • Ueki K; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
  • Kosaka Y; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
  • Kimino G; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
  • Imagumbai T; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
  • Takayama K; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
  • Kokubo M; Division of Radiation Oncology, Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047 Japan.
Int Cancer Conf J ; 5(4): 214-218, 2016 Oct.
Article in En | MEDLINE | ID: mdl-31149457

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int Cancer Conf J Year: 2016 Document type: Article Country of publication: Singapore

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int Cancer Conf J Year: 2016 Document type: Article Country of publication: Singapore